Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance)Laura J. Esserman, David M. Ota, Amy Brink et al.|UNC Libraries|2020Cited by 0
Supplementary Data from Artificial Intelligence–Assisted Amphiregulin and Epiregulin IHC Predicts Panitumumab Benefit in <i>RAS</i> Wild-Type Metastatic Colorectal CancerChristopher J.M. Williams, Kandavel Shanmugam, Susan D. Richman et al.|Unknown|2023Cited by 0